Genetic and early environmental influences on the serotonin system: consequences for brain development and risk for psychopathology
- PMID: 25285876
- PMCID: PMC4275332
- DOI: 10.1503/jpn.140099
Genetic and early environmental influences on the serotonin system: consequences for brain development and risk for psychopathology
Abstract
Background: Despite more than 60 years of research in the role of serotonin (5-HT) in psychopathology, many questions still remain. From a developmental perspective, studies have provided more insight into how 5-HT dysfunctions acquired in utero or early in life may modulate brain development. This paper discusses the relevance of the developmental role of 5-HT for the understanding of psychopathology. We review developmental milestones of the 5-HT system, how genetic and environmental 5-HT disturbances could affect brain development and the potential role of DNA methylation in 5-HT genes for brain development.
Methods: Studies were identified using common databases (e.g., PubMed, Google Scholar) and reference lists.
Results: Despite the widely supported view that the 5-HT system matures in early life, different 5-HT receptors, proteins and enzymes have different developmental patterns, and development is brain region-specific. A disruption in 5-HT homeostasis during development may lead to structural and functional changes in brain circuits that modulate emotional stress responses, including subcortical limbic and (pre)frontal areas. This may result in a predisposition to psychopathology. DNA methylation might be one of the underlying physiologic mechanisms.
Limitations: There is a need for prospective studies. The impact of stressors during adolescence on the 5-HT system is understudied. Questions regarding efficacy of drugs acting on 5-HT still remain.
Conclusion: A multidisciplinary and longitudinal approach in designing studies on the role of 5-HT in psychopathology might help to bring us closer to the understanding of the role of 5-HT in psychopathology.
Figures
References
-
- Twarog BM, Page IH. Serotonin content of some mammalian tissues and urine and a method for its determination. Am J Physiol. 1953;175:157–61. - PubMed
-
- Sjoerdsma A, Palfreyman MG. History of serotonin and serotinin disorders. Ann N Y Acad Sci. 1990;600:1–7. discussion 7–8. - PubMed
-
- Ashcroft GW, Crawford TB, Eccleston D, et al. 5-hydroxyindole compounds in the cerebrospinal fluid of patients with psychiatric or neurological diseases. Lancet. 1966;2:1049–52. - PubMed
-
- Carlsson A. Structural specificity for inhibition of [14C]-5- hydroxytryptamine uptake by cerebral slices. J Pharm Pharmacol. 1970;22:729–32. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
